<?xml version="1.0" encoding="ISO-8859-1" ?>
<rss version="0.91">
<channel>
<title>Latest press releases for abbott</title>
<link>http://www.free-press-release-center.info</link>
<description>Latest press releases for abbott from the Free Press Release Center</description>
<item>
<title>Abbott's HUMIRA® Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis</title>
<link>http://www.free-press-release-center.info/pr00000000000000009644.html</link>
<description>Abbott has received marketing authorization from the European Commission for the use of HUMIRA® (adalimumab) as a treatment for moderate-to-severe plaque psoriasis.</description>
</item>
</channel>
</rss>
